Tech Company Financing Transactions
ZIOPHARM Oncology Funding Round
Private investors participated in a $120 million funding round for ZIOPHARM Oncology. The round was announced on 7/8/2016.
Transaction Overview
Company Name
Announced On
7/8/2016
Transaction Type
Venture Equity
Amount
$120,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 First Ave. Parris Building 34
Boston, MA 02129
USA
Boston, MA 02129
USA
Phone
Website
Email Address
Overview
Operations were initiated in January 2004 with the strategy of in-licensing proprietary drug candidate families with prior related-molecule efficacy in human cancer that would be efficiently and effectively developed and commercialized by a very experienced management team supported by prominent clinicians and medical advisors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laurence Cooper
Chief Financial Officer
Satyavrat Shukla
President
David Mauney
VP - Bus. Development
Eleanor de Groot
VP - General Counsel
Robert Hadfield
VP - Human Resources
Lynn Ferrucci
VP - Operations
Jill Buck
Browse more venture capital transactions:
Prev: 7/8/2016: People Power venture capital transaction
Next: 7/11/2016: Vigilant Biosciences venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs